Form D · Biotechnology
Evoke Pharma Inc
San Diego, CA · CIK 0001403708
Offering snapshot reported Jun 30, 2010 · SEC filing
- Reported sold
- $6M Offering amount: $6M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 16, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 30, 2010 | Initial | $6,000,001 | No comparison | 20 | SEC filing |
| Jun 11, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-144215
Source: Form D, filed Jun 30, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Todd Brady | Director |
| Matt D'onofrio | Executive |
| Cam L. Garner | Director |
| Scott L. Glenn | Director |
| David A. Gonyer | Director, Executive |
| Malcolm R. Hill | Director |
| Kenneth J. Widder | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12671 High Bluff Drive Suite 200
San Diego, CA, 92130
San Diego, CA, 92130